Action A206640 BODITECH MED INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Boditech Med Inc.

Actions

A206640

KR7206640005

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 07/06/2024 		Varia. 5j. Varia. 1 janv.
17 170 KRW -1,89 % Graphique intraday de Boditech Med Inc. -2,77 % -16,24 %
2023 Boditech Med Inc. et SphingoTec GmbH concluent un accord de développement du marché pour stimuler la commercialisation du biomarqueur de la fonction rénale PenKid CI
2022 Boditech Med Inc. et SphingoTec GmbH concluent un accord de licence non exclusif assorti de redevances CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
4TEEN4 Pharmaceuticals GmbH announced that it has received funding from Boditech Med Inc.
Boditech Med Inc. and SphingoTec GmbH Enter into Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
MENARINI ANNOUNCES AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR BODITECH'S AFIAS-10 SYSTEM
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.
Boditech Med Inc.'s Equity Buyback announced on September 29, 2022, has expired with 496,620 shares, representing 2.21% for KRW 4,994.56 million
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 29, 2022.
Boditech Med Inc. and SphingoTec GmbH Enters into Non-Exclusive Royalty-Bearing License Agreement
Boditech Med Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Boditech Med Inc. authorizes a Buyback Plan.
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.
Boditech Med Inc.'s Equity Buyback announced on December 14, 2021, has expired with 297,901 shares, representing 1.31% for KRW 4,987.06 million.
Novo Integrated Sciences, Boditech Med Sign Memorandum of Understanding for Distribution of Diagnostic Technologies
Novo Integrated Sciences, Inc. Signs Memorandum of Understanding with Boditech Med to Market and Distribute in North America
Boditech Med Announces the Formation of a U.S. Based Advisory Board and its First Member, Zachariah P. Zachariah, M.D
Boditech Med Partners with Novo Integrated Sciences, Inc. to Market and Distribute Lower-Cost, Rapid Testing in North America
Boditech Med to Expand to U.S., North America
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on December 14, 2021.
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.
Tranche Update on Boditech Med Inc.'s Equity Buyback Plan announced on September 6, 2021.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A206640
  4. Actualités Boditech Med Inc.
  5. Autres langues